相似文献
1
Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.
J Clin Microbiol. 2005 Oct;43(10):5312-5. doi: 10.1128/JCM.43.10.5312-5315.2005.
2
Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants.
J Clin Microbiol. 2001 Mar;39(3):1017-20. doi: 10.1128/JCM.39.3.1017-1020.2001.
3
Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, Ivory Coast.
J Clin Microbiol. 2001 May;39(5):1808-12. doi: 10.1128/JCM.39.5.1808-1812.2001.
4
Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu, Western Kenya.
J Virol Methods. 2011 Sep;176(1-2):24-31. doi: 10.1016/j.jviromet.2011.05.021. Epub 2011 May 27.
5
6
Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2 in the setting of multiple transmitted viral subtypes.
Int J STD AIDS. 2002 Mar;13(3):171-3. doi: 10.1258/0956462021924857.
7
Comparison of turnaround time and total cost of HIV testing before and after implementation of the 2014 CDC/APHL Laboratory Testing Algorithm for diagnosis of HIV infection.
J Clin Virol. 2017 Jun;91:69-72. doi: 10.1016/j.jcv.2017.04.004. Epub 2017 Apr 6.
8
Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.
Arch Intern Med. 2010 Jan 11;170(1):66-74. doi: 10.1001/archinternmed.2009.445.
9
Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.
J Clin Microbiol. 2001 Jul;39(7):2572-5. doi: 10.1128/JCM.39.7.2572-2575.2001.
10
Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections.
J Clin Virol. 2011 Dec;52 Suppl 1:S17-22. doi: 10.1016/j.jcv.2011.09.011. Epub 2011 Oct 5.
引用本文的文献
1
Misclassification of HIV infection status among serologically diverse populations in Nigeria: implications for test and treat program.
BMC Health Serv Res. 2025 Mar 26;25(1):430. doi: 10.1186/s12913-025-12617-9.
2
Designing HIV Testing Algorithms Based on 2015 WHO Guidelines Using Data from Six Sites in Sub-Saharan Africa.
J Clin Microbiol. 2017 Oct;55(10):3006-3015. doi: 10.1128/JCM.00962-17. Epub 2017 Jul 26.
3
HIV misdiagnosis in sub-Saharan Africa: performance of diagnostic algorithms at six testing sites.
J Int AIDS Soc. 2017 Jul 3;20(1):21419. doi: 10.7448/IAS.20.1.21419.
4
Towards more accurate HIV testing in sub-Saharan Africa: a multi-site evaluation of HIV RDTs and risk factors for false positives.
J Int AIDS Soc. 2017 Mar 24;19(1):21345. doi: 10.7448/IAS.20.1.21345.
5
Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in Nigeria.
J Clin Microbiol. 2015 Nov;53(11):3501-6. doi: 10.1128/JCM.01432-15. Epub 2015 Aug 26.
6
Evaluation of HIV testing algorithms in Ethiopia: the role of the tie-breaker algorithm and weakly reacting test lines in contributing to a high rate of false positive HIV diagnoses.
BMC Infect Dis. 2015 Feb 3;15:39. doi: 10.1186/s12879-015-0769-3.
7
Low specificity of determine HIV1/2 RDT using whole blood in south west Tanzania.
PLoS One. 2012;7(6):e39529. doi: 10.1371/journal.pone.0039529. Epub 2012 Jun 29.
8
Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial.
Clin Vaccine Immunol. 2011 Sep;18(9):1480-5. doi: 10.1128/CVI.05069-11. Epub 2011 Jul 13.
9
Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.
J Clin Microbiol. 2010 Apr;48(4):1333-6. doi: 10.1128/JCM.01734-09. Epub 2010 Feb 3.
10
The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm.
PLoS One. 2009;4(2):e4351. doi: 10.1371/journal.pone.0004351. Epub 2009 Feb 6.
本文引用的文献
1
Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory.
J Clin Microbiol. 2004 Aug;42(8):3850-2. doi: 10.1128/JCM.42.8.3850-3852.2004.
2
Burden of infection among heads and non-head of rural households in Rakai, Uganda.
AIDS Care. 2004 Jan;16(1):107-15. doi: 10.1080/09540120310001634010.
3
Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2.
J Clin Microbiol. 2003 Aug;41(8):3868-9. doi: 10.1128/JCM.41.8.3868-3869.2003.
4
Discrepant results of 2 screening tests for anti-HIV antibody.
Clin Infect Dis. 2002 Sep 15;35(6):773-4; author reply 774-5. doi: 10.1086/341985.
5
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
MMWR Recomm Rep. 2001 Jun 29;50(RR-11):1-52.
6
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
J Infect Dis. 2000 Mar;181(3):881-9. doi: 10.1086/315308.
7
The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania.
J Clin Virol. 1999 Sep;14(1):25-9. doi: 10.1016/s1386-6532(99)00043-8.
8
Simple/rapid test devices for anti-HIV screening: do they come up to the mark?
J Med Virol. 1999 Sep;59(1):104-9.
9
Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.
JAMA. 1999 Mar 10;281(10):931-6. doi: 10.1001/jama.281.10.931.
10
Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.
J Virol. 1998 May;72(5):4265-73. doi: 10.1128/JVI.72.5.4265-4273.1998.
Zotero 插件